Metlife (MET) AI Stock Analysis

• Market Cap: $53.88B
• Dividend Yield: 2.78%
• Average Volume (3M): 2.94M
• Price to Earnings (P/E): 15.4
• Beta (1Y): 0.89
• Revenue Growth: 0.82%
• EPS Growth: 7.18%
• Country: US
• Employees: 45,000
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Life
• EPS (TTM): 2.34
• Shares Outstanding: 658,891,660
• 10 Day Avg. Volume: 1,667,412
• 30 Day Avg. Volume: 2,941,693
• PEG Ratio: 0.06
• Price to Book (P/B): 2.06
• Price to Sales (P/S): 0.81
• P/FCF Ratio: 3.73
• Enterprise Value/Market Cap: 1.40
• Enterprise Value/Revenue: 1.07
• Enterprise Value/Gross Profit: 4.43
• Enterprise Value/Ebitda: 12.64
• 1Y Price Target: $94.33
• Price Target Upside: 16.20% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 12
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 70 Outperform
• Price Target: $88.00 ▲(8.40% Upside)

MET scores 70 primarily due to solid (but mixed) financial fundamentals and a positive earnings-call read-through showing strong segment performance and capital returns. Valuation is reasonable with a supportive dividend, while technical indicators are mostly neutral and do not add strong momentum to the outlook.

Positive Factors

Strong Earnings Growth

The significant growth in earnings reflects MetLife's effective business strategies and operational efficiency, strengthening its market position and financial health.

Expansion in Asset Management

This acquisition enhances MetLife's asset management capabilities, diversifying revenue streams and positioning it as a top-tier global asset manager.

Efficient Expense Management

Improved expense management indicates operational efficiency, contributing to higher profitability and competitive advantage in the long term.

Negative Factors

Impact of Reinsurance Transactions

The reduction in earnings due to reinsurance transactions may impact profitability, highlighting potential challenges in managing legacy business risks.

Mexico Tax Law Impact

The tax law change introduces financial uncertainty and could affect MetLife's earnings in Latin America, impacting its regional growth strategy.

Decline in Free Cash Flow Growth

A decline in free cash flow growth may constrain MetLife's ability to invest in growth opportunities and return capital to shareholders.

Metlife Business Overview & Revenue Model

Company Description

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

How the Company Makes Money

MetLife generates revenue primarily through premiums collected from its insurance policies, which include life, health, and property insurance. The company also earns income from investment returns on its extensive portfolio of assets, which is comprised of bonds, equities, and real estate. Additionally, MetLife generates revenue from fees associated with its retirement and income solutions, such as annuities and pension plans. Key revenue streams include U.S. Life Insurance and Group Benefits, which provide substantial contributions to the overall earnings. Strategic partnerships with employers for group benefits and collaborations with financial advisors for retirement solutions also enhance its revenue potential. Furthermore, the company benefits from economies of scale and a diversified product offering, allowing it to mitigate risks and capitalize on various market opportunities.

Metlife Financial Statement Overview

Summary

MetLife demonstrates a stable financial foundation with a strong balance sheet and consistent cash flow generation. However, the company faces challenges in revenue and profit growth, as indicated by declining margins and negative growth rates in the TTM period. While the debt levels are manageable, careful attention is needed to sustain profitability and improve growth trajectories in the competitive insurance industry.

Income Statement

Metlife's income statement shows a mixed performance. The TTM data indicates a decline in revenue growth rate by 1.96%, and a decrease in net profit margin to 5.39% from 6.33% in the previous year. The gross profit margin also decreased to 19.83% from 27.17%. However, the company maintains a reasonable EBIT margin of 8.40%. Overall, the company faces challenges in revenue growth and profitability, but maintains stable operational efficiency.

Balance Sheet

The balance sheet reflects a stable financial position with a manageable debt-to-equity ratio of 0.70 in the TTM period. The return on equity is 13.77%, indicating effective use of equity to generate profits. The equity ratio stands at a healthy level, suggesting a solid capital structure. However, the slight increase in debt levels over the years could pose a risk if not managed carefully.

Cash Flow

Cash flow analysis reveals a decline in free cash flow growth by 3.82% in the TTM period, indicating potential challenges in cash generation. The operating cash flow to net income ratio is not available for the TTM, but the free cash flow to net income ratio remains strong at 1.0, suggesting that the company generates sufficient cash relative to its net income. Overall, cash flow management appears stable, but growth concerns persist.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	70.76B	69.94B	67.71B	67.97B	63.37B	67.89B
Gross Profit	17.06B	19.00B	17.29B	18.94B	16.84B	15.47B
EBITDA	5.98B	7.37B	3.92B	7.97B	10.13B	8.46B
Net Income	3.84B	4.43B	1.58B	5.28B	6.86B	5.41B
Balance Sheet
Total Assets	719.73B	677.46B	687.58B	663.07B	759.71B	795.15B
Cash, Cash Equivalents and Short-Term Investments	114.77B	100.57B	302.05B	301.91B	367.50B	378.51B
Total Debt	19.83B	18.71B	18.83B	17.98B	17.43B	18.15B
Total Liabilities	690.53B	649.75B	657.33B	632.95B	691.96B	720.33B
Stockholders Equity	28.94B	27.45B	30.02B	29.88B	67.48B	74.56B
Cash Flow
Free Cash Flow	15.14B	15.12B	14.26B	11.37B	12.83B	11.51B
Operating Cash Flow	15.14B	15.12B	14.26B	11.37B	12.83B	11.51B
Investing Cash Flow	-16.68B	-11.49B	-10.25B	-2.62B	-11.19B	-18.57B
Financing Cash Flow	642.00M	-3.13B	-2.94B	-9.95B	-1.38B	10.73B

Metlife Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 81.18
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MET, the sentiment is Positive. The current price of 81.18 is above the 20-day moving average (MA) of 80.82, above the 50-day MA of 78.68, and above the 200-day MA of 77.73, indicating a bullish trend. The MACD of 0.58 indicates Positive momentum. The RSI at 56.51 is Neutral, neither overbought nor oversold. The STOCH value of 63.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MET.

Metlife Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PRU	77 Outperform	$41.08B	16.09	8.36%	4.73%	-19.35%	-35.23%
LNC	71 Outperform	$8.78B	4.15	21.66%	3.93%	35.76%	636.97%
MET	70 Outperform	$53.88B	15.40	12.84%	2.78%	0.82%	7.18%
AFL	68 Neutral	$58.80B	14.63	15.58%	2.10%	2.31%	15.46%
GL	68 Neutral	$11.19B	10.19	22.28%	0.74%	3.73%	17.47%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
UNM	64 Neutral	$13.10B	15.25	8.35%	2.22%	1.80%	-44.44%

Metlife Corporate Events

MetLife Completes PineBridge Acquisition, Expanding Global Asset Management

On December 30, 2025, MetLife Investment Management closed its acquisition of PineBridge Investments, creating a combined institutional asset management business with $734.7 billion in pro forma assets under management and significantly expanding MetLife’s global reach, particularly among non-U.S. clients, with a notable concentration in Asia. The deal, part of MetLife’s New Frontier strategy to accelerate growth in asset management, positions MIM as a more diversified, top-tier global asset manager, supported by a newly announced leadership team led by MIM president Brian Funk and combining senior talent from both firms, while excluding PineBridge’s private equity funds group and its China joint venture from the transaction.

The most recent analyst rating on (MET) stock is a Buy with a $90.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.

MetLife Updates 2025 Results Outlook and Capital Plans

MetLife disclosed preliminary variable investment income results and capital management plans for the fourth quarter and full year 2025, ahead of its scheduled February 4, 2026 earnings release. For the quarter ending December 31, 2025, the company estimates variable investment income of $385 million to $435 million pre-tax versus a $425 million target, and for full-year 2025 it anticipates a 7.7% return on its private equity portfolio. Looking to 2026, MetLife plans to assume a 9% annual return on private equity, contributing to an estimated $1.6 billion of pre-tax variable investment income for that year, while expecting variable investment income asset balances to decline over the next one to three years. On capital deployment, MetLife intends to prioritize organic growth with about $4 billion earmarked for 2025, plus roughly $1 billion to support M&A including the pending PineBridge Investments acquisition; it also projects about $2.85 billion of common stock repurchases in 2025, including approximately $430 million in the fourth quarter, and anticipates similar buyback levels in 2026, signaling continued emphasis on shareholder returns alongside growth investments.

The most recent analyst rating on (MET) stock is a Buy with a $101.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.

MetLife Completes $10 Billion Risk Transfer Deal

On December 1, 2025, MetLife, Inc. announced the completion of a $10 billion variable annuity risk transfer transaction with Talcott Resolution Life Insurance Company. This transaction is part of MetLife’s strategy to reduce portfolio risk and accelerate the run-off of its legacy business blocks, resulting in expected annual adjusted earnings loss of approximately $100 million, partially offset by $45 million in hedge cost savings. MetLife Investment Management will manage around $6 billion of assets under investment management agreements with Talcott.

The most recent analyst rating on (MET) stock is a Hold with a $86.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.

MetLife Announces Quarterly Dividends for Preferred Stock

On November 17, 2025, MetLife, Inc. announced the declaration of quarterly dividends for its preferred stock series. The dividends, payable on December 15, 2025, include $0.33489390 per share for Series A, $351.5625 per share for Series E, and $296.875 per share for Series F, with respective depositary shares receiving $0.3515625 and $0.296875. This announcement reflects MetLife’s ongoing commitment to providing returns to its shareholders and maintaining its strong market position.

The most recent analyst rating on (MET) stock is a Hold with a $86.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.

MetLife Reports Strong Q3 2025 Financial Results

MetLife, Inc. announced its third-quarter 2025 financial results, reporting a net income of $818 million, or $1.22 per share, and adjusted earnings of $1.6 billion, marking a 15% increase from the previous year. The company experienced growth in variable investment income and volume, with adjusted earnings per share rising 21% to $2.34. MetLife also reported a 16% increase in net investment income and returned $875 million to shareholders through share repurchases and dividends. The company secured $12 billion in pension risk transfer mandates and expanded its operations in Asia and Latin America, reflecting strategic growth initiatives.

The most recent analyst rating on (MET) stock is a Buy with a $86.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.

MetLife Eliminates Series G Preferred Stock

On October 14, 2025, MetLife, Inc. filed a Certificate of Elimination with the Delaware Secretary of State to eliminate its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, which had been previously redeemed or reacquired. This action returned the shares to the status of authorized but unissued preferred stock, impacting the company’s capital structure by removing the specific designation of the Series G shares.

The most recent analyst rating on (MET) stock is a Buy with a $104.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.